ReviewCancer immunology, immunotherapy : CII2015

Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapy.

Peter F Mulders et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.